RNF7

Across TCGA pan-cancer cohorts, RNF7 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RNF7 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNF7 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNF7 expression acts as an unfavorable survival marker.

THCA and LUSC are the cancer types where RNF7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	All	0.049	0.841	<.001	24	view →
LUSC	DFS	Median	All	0.027	0.758	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNF7–THCA (DFS)

Open the THCA breakdown →